Medical information departments help connect pharmaceutical companies with healthcare providers and patients. Their job is to give up-to-date, accurate, and regulation-following information about drugs and treatments. Recently, this work has become harder.
One big problem for MI teams is the large number of questions they get. New therapies like biologics, cell therapies, and gene therapies mean more healthcare workers, pharmacists, and patients have questions about how to use these treatments, their side effects, and other important details. These questions are not only more but also more complicated.
Simon Johns, Director of Medical Information and Marketed Product Safety, says MI teams now face more difficult situations. Before new therapies appeared, MI teams handled simpler questions. Today, they need expert knowledge and must follow strict rules. Often, the number of questions is too much for people alone to answer well and fast.
Many new therapies treat hard diseases like cancer, rare genetic problems, and autoimmune disorders. Treatments like cell and gene therapies need deep knowledge, special patient details, and fresh clinical information. MI teams must always keep up with changes in science and rules for each treatment. This is a big and ongoing job.
Also, U.S. agencies like the FDA set strong rules on how drug information should be shared. MI teams have to make sure all communication follows these rules and avoid giving any unapproved information. This makes answering questions tricky, as teams must be careful and exact to avoid legal issues.
Rules have become more complex. MI staff must know more than basic drug labels and instructions. They must also understand safety monitoring, risk plans, and changing compliance rules. Different rules apply depending on the therapy and its approval stage. MI workers need to be both medically skilled and knowledgeable about regulations.
Louise Molloy, Associate Director of Medical Information and Pharmacovigilance, says drug sponsors are using technology to help MI teams. Because questions are many and complex, following rules is very important, and technology helps keep answers consistent and documented.
To meet these problems, U.S. pharmaceutical and healthcare industries are using artificial intelligence (AI) and automation tools more often. Advances in language technology, like ChatGPT and Generative AI, help handle many medical questions quickly and safely.
AI tools can answer many simple or repeated questions automatically. This lowers the workload for human experts, who then focus on harder questions. AI can be the first contact and give quick answers about drug use, side effects, doses, and how to take medicines.
For example, if a doctor asks about a common drug, AI can instantly provide correct and regulation-approved answers. This shortens waiting time. If the question is more complex, it is sent to a human expert.
AI lets patients, pharmacists, and healthcare workers choose to talk to AI or a human agent, based on what they want or the question type. This choice helps keep more questions answered and supports 24/7 access without needing more staff.
AI systems also analyze data from conversations in real time. This helps human experts see common topics or safety concerns and update their responses and training materials quickly.
By cutting down repeated work, AI lowers mental and physical tiredness for MI workers. When they don’t spend so much time on simple questions, they can focus on tough cases and learning new information.
Automation also helps keep answers consistent and in line with rules. This reduces mistakes and the need for lots of manual checks, which lowers stress on the team.
Organizations in the U.S. are trying AI tools made for their needs. For example, companies like IQVIA create AI medical information services designed for online healthcare. These systems use AI chatbots to answer questions quickly and accurately for many treatment areas.
Besides pharma companies, hospitals and clinics can also use AI phone systems. Automating call answers in busy places helps reduce wait times and lets doctors and nurses spend more time caring for patients.
Simon Johns points out that the old way of only using human call centers is not enough now. He says AI isn’t meant to replace humans but to help them. This helps keep information good and safe while answering questions fast.
Louise Molloy adds that AI helps drug companies and MI teams handle questions without overloading staff. This is important when dealing with complicated therapies like gene treatments. AI also supports correct and ethical communications by checking compliance and using approved information.
Medical practice managers, healthcare owners, and IT staff in the U.S. need to know how AI can help MI work. Using AI and automation in phone and digital communication can help:
Making AI work well needs cooperation among managers, healthcare workers, and IT teams. Staff training is also needed so people can work well with AI tools and keep things running smoothly.
Using AI in medical information services offers a practical way to meet the rising challenges caused by new treatments and complex rules. As U.S. healthcare changes with new therapies and more oversight, AI and automation will become key parts of keeping high-quality medical information available without tiring out staff or losing accuracy. Medical practice leaders who stay updated and active with these tools can help improve operations and patient care.
MI teams are facing increased volumes and complexity of inquiries as drug companies expand access to therapeutics. They’re also dealing with distinct regulatory protocols and the need for knowledge on complex therapies like cell and gene treatments.
AI can enhance MI workflows by supporting high inquiry volumes, minimizing resource impact, providing engagement options to reduce inquiry abandonment, and offering customers a choice between AI and human specialists.
AI aims to improve customer service quality by maintaining high response rates, enhancing satisfaction, and allowing human MI experts to focus on more complex inquiries.
The goals include easing MI staff burnout, improving efficiency and quality of service, and creating synergy between human agents and AI.
AI can help redistribute inquiry volume by handling simpler questions and allowing MI staff to focus on more complicated issues.
Companies are integrating AI technologies such as ChatGPT and Generative AI (GenAI) to enhance the efficiency of their MI capabilities.
Real-time data analysis empowers human agents by providing them with insights that enhance their ability to serve customers effectively and make informed decisions.
AI improves customer engagement by providing options for self-service and quick responses, which can lead to decreased inquiry abandonment and enhanced satisfaction.
High-quality customer service is crucial in MI to ensure that inquiries are satisfactorily addressed, thereby fostering trust and maintaining compliance in disseminating medical information.
There is skepticism surrounding AI’s capabilities; however, many drug companies recognize its potential to address growing challenges and improve MI workflows.